358 related articles for article (PubMed ID: 24887489)
1. Timing of vasopressor initiation and mortality in septic shock: a cohort study.
Beck V; Chateau D; Bryson GL; Pisipati A; Zanotti S; Parrillo JE; Kumar A;
Crit Care; 2014 May; 18(3):R97. PubMed ID: 24887489
[TBL] [Abstract][Full Text] [Related]
2. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.
Kumar A; Roberts D; Wood KE; Light B; Parrillo JE; Sharma S; Suppes R; Feinstein D; Zanotti S; Taiberg L; Gurka D; Kumar A; Cheang M
Crit Care Med; 2006 Jun; 34(6):1589-96. PubMed ID: 16625125
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Vasopressor Exposure and Mortality in Patients With Septic Shock.
Roberts RJ; Miano TA; Hammond DA; Patel GP; Chen JT; Phillips KM; Lopez N; Kashani K; Qadir N; Cairns CB; Mathews K; Park P; Khan A; Gilmore JF; Brown ART; Tsuei B; Handzel M; Chang AL; Duggal A; Lanspa M; Herbert JT; Martinez A; Tonna J; Ammar MA; Nazer LH; Heavner M; Pender E; Chambers L; Kenes MT; Kaufman D; Downey A; Brown B; Chaykosky D; Wolff A; Smith M; Nault K; Gong MN; Sevransky JE; Lat I;
Crit Care Med; 2020 Oct; 48(10):1445-1453. PubMed ID: 32706559
[TBL] [Abstract][Full Text] [Related]
4. Delayed vasopressor initiation is associated with increased mortality in patients with septic shock.
Colon Hidalgo D; Patel J; Masic D; Park D; Rech MA
J Crit Care; 2020 Feb; 55():145-148. PubMed ID: 31731173
[TBL] [Abstract][Full Text] [Related]
5. Impact of Hyperoncotic Albumin on Duration of Vasopressor Support in Septic Shock: A Propensity Score-Matched Analysis.
Flannery AH; Owen GD; Coz A; Thompson Bastin ML; Patel K
Ann Pharmacother; 2021 May; 55(5):584-591. PubMed ID: 33016080
[TBL] [Abstract][Full Text] [Related]
6. Early initiation of low-dose corticosteroid therapy in the management of septic shock: a retrospective observational study.
Park HY; Suh GY; Song JU; Yoo H; Jo IJ; Shin TG; Lim SY; Woo S; Jeon K
Crit Care; 2012 Jan; 16(1):R3. PubMed ID: 22226237
[TBL] [Abstract][Full Text] [Related]
7. Early reversible acute kidney injury is associated with improved survival in septic shock.
Sood MM; Shafer LA; Ho J; Reslerova M; Martinka G; Keenan S; Dial S; Wood G; Rigatto C; Kumar A;
J Crit Care; 2014 Oct; 29(5):711-7. PubMed ID: 24927984
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis.
Arabi YM; Dara SI; Memish Z; Al Abdulkareem A; Tamim HM; Al-Shirawi N; Parrillo JE; Dodek P; Lapinsky S; Feinstein D; Wood G; Dial S; Zanotti S; Kumar A;
Hepatology; 2012 Dec; 56(6):2305-15. PubMed ID: 22753144
[TBL] [Abstract][Full Text] [Related]
9. Intensity of Vasopressor Therapy for Septic Shock and the Risk of In-Hospital Death.
Brand DA; Patrick PA; Berger JT; Ibrahim M; Matela A; Upadhyay S; Spiegler P
J Pain Symptom Manage; 2017 May; 53(5):938-943. PubMed ID: 28062334
[TBL] [Abstract][Full Text] [Related]
10. The Timing of Initiating Hydrocortisone and Long-term Mortality in Septic Shock.
Zhang L; Gu WJ; Huang T; Lyu J; Yin H
Anesth Analg; 2023 Oct; 137(4):850-858. PubMed ID: 37171987
[TBL] [Abstract][Full Text] [Related]
11. Liberal vs. conservative vasopressor use to maintain mean arterial blood pressure during resuscitation of septic shock: an observational study.
Subramanian S; Yilmaz M; Rehman A; Hubmayr RD; Afessa B; Gajic O
Intensive Care Med; 2008 Jan; 34(1):157-62. PubMed ID: 17924093
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Initiation Timing of Hydrocortisone in Adult Patients With Septic Shock.
Sacha GL; Chen AY; Palm NM; Duggal A
Shock; 2021 Apr; 55(4):488-494. PubMed ID: 32890314
[TBL] [Abstract][Full Text] [Related]
13. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
Póvoa PR; Carneiro AH; Ribeiro OS; Pereira AC;
Crit Care Med; 2009 Feb; 37(2):410-6. PubMed ID: 19114885
[TBL] [Abstract][Full Text] [Related]
14. Evaluating Vasopressor Discontinuation Strategies in Patients With Septic Shock on Concomitant Norepinephrine and Vasopressin Infusions.
Musallam N; Altshuler D; Merchan C; Zakhary B; Aberle C; Papadopoulos J
Ann Pharmacother; 2018 Aug; 52(8):733-739. PubMed ID: 29560736
[TBL] [Abstract][Full Text] [Related]
15. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.
Briegel J; Forst H; Haller M; Schelling G; Kilger E; Kuprat G; Hemmer B; Hummel T; Lenhart A; Heyduck M; Stoll C; Peter K
Crit Care Med; 1999 Apr; 27(4):723-32. PubMed ID: 10321661
[TBL] [Abstract][Full Text] [Related]
16. Timing of vasopressin initiation and mortality in patients with septic shock: analysis of the MIMIC-III and MIMIC-IV databases.
Xu J; Cai H; Zheng X
BMC Infect Dis; 2023 Apr; 23(1):199. PubMed ID: 37013474
[TBL] [Abstract][Full Text] [Related]
17. Continuation of Statin Therapy and Vasopressor Use in Septic Shock.
Zechmeister C; Hurren J; McNorton K
Ann Pharmacother; 2015 Jul; 49(7):790-5. PubMed ID: 25896127
[TBL] [Abstract][Full Text] [Related]
18. Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy.
Bagshaw SM; Lapinsky S; Dial S; Arabi Y; Dodek P; Wood G; Ellis P; Guzman J; Marshall J; Parrillo JE; Skrobik Y; Kumar A;
Intensive Care Med; 2009 May; 35(5):871-81. PubMed ID: 19066848
[TBL] [Abstract][Full Text] [Related]
19. Multi-complexity measures of heart rate variability and the effect of vasopressor titration: a prospective cohort study of patients with septic shock.
Brown SM; Sorensen J; Lanspa MJ; Rondina MT; Grissom CK; Shahul S; Mathews VJ
BMC Infect Dis; 2016 Oct; 16(1):551. PubMed ID: 27724850
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of etomidate in severe sepsis and septic shock.
Dmello D; Taylor S; O'Brien J; Matuschak GM
Chest; 2010 Dec; 138(6):1327-32. PubMed ID: 20651024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
